Immune-Related Adverse Events in the Setting of PD-1/L1 Inhibitor Combination Therapy.
Zubiri L, Allen IM, Taylor MS, Guidon AC, Chen ST, Schoenfeld SR, Neilan TG, Sise ME, Mooradian MJ, Rubin KM, Leaf RK, Parikh AR, Faje A, Gainor JF, Cohen JV, Fintelmann FJ, Kohler MJ, Dougan M, Reynolds KL.
Zubiri L, et al. Among authors: chen st.
Oncologist. 2020 Mar;25(3):e398-e404. doi: 10.1634/theoncologist.2018-0883. Epub 2019 Nov 21.
Oncologist. 2020.
PMID: 32162817
Free PMC article.